123 related articles for article (PubMed ID: 24929055)
1. Different effects of lobeline on neuronal and muscle nicotinic receptors.
Kaniakova M; Skrenkova K; Adamek S; Vyskocil F; Krusek J
Eur J Pharmacol; 2014 Sep; 738():352-9. PubMed ID: 24929055
[TBL] [Abstract][Full Text] [Related]
2. Dual effect of lobeline on α4β2 rat neuronal nicotinic receptors.
Kaniaková M; Lindovský J; Krůšek J; Adámek S; Vyskočil F
Eur J Pharmacol; 2011 May; 658(2-3):108-13. PubMed ID: 21371469
[TBL] [Abstract][Full Text] [Related]
3. Effect of tissue-specific acetylcholinesterase inhibitor C-547 on α3β4 and αβεδ acetylcholine receptors in COS cells.
Lindovský J; Petrov K; Krůšek J; Reznik VS; Nikolsky EE; Vyskočil F
Eur J Pharmacol; 2012 Aug; 688(1-3):22-6. PubMed ID: 22634638
[TBL] [Abstract][Full Text] [Related]
4. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
Lim DY; Kim YS; Miwa S
Auton Neurosci; 2004 Jan; 110(1):27-35. PubMed ID: 14766322
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural interaction of (-)-lobeline with human α4β2 and α4β4 nicotinic acetylcholine receptor subtypes.
Arias HR; Feuerbach D; Ortells M
Int J Biochem Cell Biol; 2015 Jul; 64():15-24. PubMed ID: 25794424
[TBL] [Abstract][Full Text] [Related]
6. The functional influence of nicotinic cholinergic receptors on the visual responses of neurones in the superficial superior colliculus.
Binns KE; Salt TE
Vis Neurosci; 2000; 17(2):283-9. PubMed ID: 10824682
[TBL] [Abstract][Full Text] [Related]
7. Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine.
Cunningham CS; Polston JE; Jany JR; Segert IL; Miller DK
Drug Alcohol Depend; 2006 Oct; 84(3):211-22. PubMed ID: 16500038
[TBL] [Abstract][Full Text] [Related]
8. The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain.
de Filippi G; Mogg AJ; Phillips KG; Zwart R; Sher E; Chen Y
Eur J Pharmacol; 2010 Sep; 643(2-3):218-24. PubMed ID: 20624387
[TBL] [Abstract][Full Text] [Related]
9. Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine receptors by choline.
Zwart R; Vijverberg HP
Eur J Pharmacol; 2000 Mar; 393(1-3):209-14. PubMed ID: 10771015
[TBL] [Abstract][Full Text] [Related]
10. Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.
Herrero CJ; García-Palomero E; Pintado AJ; García AG; Montiel C
Br J Pharmacol; 1999 Jul; 127(6):1375-87. PubMed ID: 10455287
[TBL] [Abstract][Full Text] [Related]
11. Piperidine, pyridine alkaloid inhibition of fetal movement in a day 40 pregnant goat model.
Green BT; Lee ST; Welch KD; Pfister JA; Panter KE
Food Chem Toxicol; 2013 Aug; 58():8-13. PubMed ID: 23603380
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of the nicotinic acetylcholine receptor by physostigmine.
Svobodová L; Krusek J; Hendrych T; Vyskocil F
Ann N Y Acad Sci; 2005 Jun; 1048():355-8. PubMed ID: 16154951
[TBL] [Abstract][Full Text] [Related]
13. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Mihalak KB; Carroll FI; Luetje CW
Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
[TBL] [Abstract][Full Text] [Related]
14. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
Pakkanen JS; Nousiainen H; Yli-Kauhaluoma J; Kylänlahti I; Möykkynen T; Korpi ER; Peng JH; Lukas RJ; Ahtee L; Tuominen RK
J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
[TBL] [Abstract][Full Text] [Related]
15. The effects of lobeline on α4β2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats.
Hillmer AT; Wooten DW; Farhoud M; Barnhart TE; Mukherjee J; Christian BT
J Neurosci Methods; 2013 Apr; 214(2):163-9. PubMed ID: 23370310
[TBL] [Abstract][Full Text] [Related]
16. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
Schrattenholz A; Pereira EF; Roth U; Weber KH; Albuquerque EX; Maelicke A
Mol Pharmacol; 1996 Jan; 49(1):1-6. PubMed ID: 8569694
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic ligands modulate ethanol-induced dopamine function in mice.
Sajja RK; Dwivedi C; Rahman S
Pharmacology; 2010; 86(3):168-73. PubMed ID: 20714207
[TBL] [Abstract][Full Text] [Related]
18. Multiple cellular mechanisms mediate the effect of lobeline on the release of norepinephrine.
Sántha E; Sperlágh B; Zelles T; Zsilla G; Tóth PT; Lendvai B; Baranyi M; Vizi ES
J Pharmacol Exp Ther; 2000 Jul; 294(1):302-7. PubMed ID: 10871326
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of lobeline, a nicotinic receptor ligand.
Damaj MI; Patrick GS; Creasy KR; Martin BR
J Pharmacol Exp Ther; 1997 Jul; 282(1):410-9. PubMed ID: 9223582
[TBL] [Abstract][Full Text] [Related]
20. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
Reitstetter R; Lukas RJ; Gruener R
J Pharmacol Exp Ther; 1999 May; 289(2):656-60. PubMed ID: 10215636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
